SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028434
Filing Date
2022-08-08
Accepted
2022-08-08 16:02:42
Documents
82
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q2 2022 kdny-10q_20220630.htm   iXBRL 10-Q 3482558
2 EX-31.1 kdny-ex311_7.htm EX-31.1 21122
3 EX-31.2 kdny-ex312_6.htm EX-31.2 21415
4 EX-32.1 kdny-ex321_8.htm EX-32.1 8133
  Complete submission text file 0001564590-22-028434.txt   12201817

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kdny-20220630.xsd EX-101.SCH 75255
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kdny-20220630_cal.xml EX-101.CAL 67143
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kdny-20220630_def.xml EX-101.DEF 207909
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE kdny-20220630_lab.xml EX-101.LAB 526895
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kdny-20220630_pre.xml EX-101.PRE 407612
76 EXTRACTED XBRL INSTANCE DOCUMENT kdny-10q_20220630_htm.xml XML 2605695
Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 221144248
SIC: 2834 Pharmaceutical Preparations